Inhibition of dUTPase represents a novel therapeutic strategy in triple negative breast cancer.

Robert Ladner, Craig Davison, Catherine Knowlson, Kienan Savage, Karl Mulligan, Peter Wilson, Patrick Johnston

Research output: Contribution to conference › Poster › peer-review

Original language	English
Publication status	Published - 2018
Event	30th EORTC-NCI-AACR Molecular Targets in Cancer Therapeutics - Dublin , Ireland Duration: 13 Nov 2018 → …

Conference	30th EORTC-NCI-AACR Molecular Targets in Cancer Therapeutics
Country/Territory	Ireland
City	Dublin
Period	13/11/2018 → …

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@conference{63f8de17f1ab447b86bb3c4b423e60e9,

title = "Inhibition of dUTPase represents a novel therapeutic strategy in triple negative breast cancer.",

author = "Robert Ladner and Craig Davison and Catherine Knowlson and Kienan Savage and Karl Mulligan and Peter Wilson and Patrick Johnston",

year = "2018",

language = "English",

note = "30th EORTC-NCI-AACR Molecular Targets in Cancer Therapeutics ; Conference date: 13-11-2018",

}

2018. Poster session presented at 30th EORTC-NCI-AACR Molecular Targets in Cancer Therapeutics, Dublin , Ireland.

Research output: Contribution to conference › Poster › peer-review

TY - CONF

T1 - Inhibition of dUTPase represents a novel therapeutic strategy in triple negative breast cancer.

AU - Ladner, Robert

AU - Davison, Craig

AU - Knowlson, Catherine

AU - Savage, Kienan

AU - Mulligan, Karl

AU - Wilson, Peter

AU - Johnston, Patrick

PY - 2018

Y1 - 2018

M3 - Poster

T2 - 30th EORTC-NCI-AACR Molecular Targets in Cancer Therapeutics

Y2 - 13 November 2018

ER -